Free Trial

Portage Biotech (PRTG) Competitors

Portage Biotech logo
$4.11 +0.01 (+0.24%)
As of 01/21/2025 04:00 PM Eastern

PRTG vs. FNCH, NKGN, BCTX, SNTI, COEP, NNVC, SYBX, GLYC, IPA, and NERV

Should you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Finch Therapeutics Group (FNCH), NKGen Biotech (NKGN), BriaCell Therapeutics (BCTX), Senti Biosciences (SNTI), Coeptis Therapeutics (COEP), NanoViricides (NNVC), Synlogic (SYBX), GlycoMimetics (GLYC), ImmunoPrecise Antibodies (IPA), and Minerva Neurosciences (NERV). These companies are all part of the "pharmaceutical products" industry.

Portage Biotech vs.

Finch Therapeutics Group (NASDAQ:FNCH) and Portage Biotech (NASDAQ:PRTG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, community ranking, profitability, analyst recommendations, valuation and dividends.

21.8% of Finch Therapeutics Group shares are held by institutional investors. Comparatively, 13.4% of Portage Biotech shares are held by institutional investors. 44.9% of Finch Therapeutics Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Finch Therapeutics Group has higher revenue and earnings than Portage Biotech. Finch Therapeutics Group is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Finch Therapeutics Group$110K161.00-$74.75M-$8.82-1.25
Portage BiotechN/AN/A-$75.34M-$41.65-0.10

Finch Therapeutics Group's return on equity of -69.14% beat Portage Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Finch Therapeutics GroupN/A -69.14% -26.92%
Portage Biotech N/A -342.34%-196.47%

Portage Biotech received 3 more outperform votes than Finch Therapeutics Group when rated by MarketBeat users. Likewise, 59.09% of users gave Portage Biotech an outperform vote while only 52.63% of users gave Finch Therapeutics Group an outperform vote.

CompanyUnderperformOutperform
Finch Therapeutics GroupOutperform Votes
10
52.63%
Underperform Votes
9
47.37%
Portage BiotechOutperform Votes
13
59.09%
Underperform Votes
9
40.91%

Finch Therapeutics Group has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500.

In the previous week, Finch Therapeutics Group's average media sentiment score of 0.00 equaled Portage Biotech'saverage media sentiment score.

Company Overall Sentiment
Finch Therapeutics Group Neutral
Portage Biotech Neutral

Summary

Finch Therapeutics Group beats Portage Biotech on 7 of the 11 factors compared between the two stocks.

Get Portage Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRTG vs. The Competition

MetricPortage BiotechPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$4.32M$6.57B$5.39B$9.13B
Dividend YieldN/A2.96%5.37%4.00%
P/E Ratio-0.1010.0188.9117.53
Price / SalesN/A315.791,280.48134.29
Price / Cash0.5122.6336.6032.90
Price / Book1.105.084.964.69
Net Income-$75.34M$154.90M$117.89M$224.57M
7 Day Performance3.53%1.33%1.68%1.69%
1 Month Performance-31.04%1.52%3.63%5.34%
1 Year Performance-79.45%4.60%26.16%21.47%

Portage Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRTG
Portage Biotech
0.0756 of 5 stars
$4.11
+0.2%
N/A-80.6%$4.32MN/A-0.106Gap Down
FNCH
Finch Therapeutics Group
N/A$10.90
-0.5%
N/A+285.9%$17.51M$110,000.00-1.24190
NKGN
NKGen Biotech
N/A$0.49
+0.2%
N/A-81.7%$17.33M$80,000.00-0.10N/A
BCTX
BriaCell Therapeutics
3.0047 of 5 stars
$0.39
-2.2%
$15.00
+3,707.1%
-90.5%$17.17MN/A-0.348Gap Up
SNTI
Senti Biosciences
2.8441 of 5 stars
$3.68
-6.4%
$10.00
+171.7%
+7.1%$16.89M$2.56M-0.244Gap Up
COEP
Coeptis Therapeutics
0.4373 of 5 stars
$8.20
+8.3%
N/A-13.5%$16.86M$80,000.00-28.282
NNVC
NanoViricides
N/A$1.21
-10.7%
N/A+4.7%$16.81MN/A-1.5920Gap Up
SYBX
Synlogic
N/A$1.40
-4.8%
N/A-55.2%$16.37M$2.78M-0.346
GLYC
GlycoMimetics
3.99 of 5 stars
$0.25
-4.3%
$8.00
+3,054.6%
-91.2%$16.35M$10,000.000.0050
IPA
ImmunoPrecise Antibodies
3.4601 of 5 stars
$0.52
-2.0%
$5.00
+865.3%
-66.7%$16.09M$24.07M-0.6680
NERV
Minerva Neurosciences
3.3536 of 5 stars
$2.24
+2.8%
$5.00
+123.2%
-71.0%$15.66MN/A-5.099Analyst Forecast
News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:PRTG) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners